|
Our Members Know First!! ERIC,HLIT,HWAY,ILMN,INCY: Sign Up Today!!
(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (NASDAQ: ERIC) Ericsson (L.M.) Telephone Co., (NASDAQ: HLIT) Harmonic, Inc., (NASDAQ: HWAY) Healthways, Inc., (NASDAQ: ILMN) Illumina, Inc., (NASDAQ: INCY) Incyte Corp.
www.StockMarketingInc.com
To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com
email us!! info@StockMarketingInc.com or call 1-866-583-8960
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ERIC - Ericsson (L.M.) Telephone Co.)
LATEST NEWS!!
Ericsson acquires Nortel's North American GSM business
Nov 25, 2009 -- Ericsson (Nasdaq: ERIC) today confirmed that it has been selected as a successful bidder to acquire assets from the Carrier Division of Nortel's (OTCBB: NRTLQ) GSM business in the US and Canada following the conclusion of Nortel's recent auction.
The transaction remains subject to approval by courts in the US and Canada and customary regulatory approvals and other conditions. Ericsson's bid for Nortel's GSM assets was made together with Kapsch CarrierCom AG of Austria. Under the agreements, Ericsson is acquiring certain assets of Nortel's GSM business in North America for USD70m while Kapsch is paying USD33m to acquire most of the remaining assets outside North America.
The acquisition means that Ericsson acquires an installed GSM base, expanding its North American footprint and strengthening the company's ability to provide a service to the region's operators. The agreement also includes the transfer of GSM business with North American operators including AT&T and T-Mobile. Nortel's North American GSM operations generated revenue of around USD400m in 2008.
Around 350 Nortel employees will be offered employment with Ericsson.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: HLIT - Harmonic, Inc.)
LATEST NEWS!!
Harmonic's Rhozet Carbon Coder Wins Streaming Media Readers' Choice Award
SUNNYVALE, Calif., Nov 25, 2009 -- Harmonic Inc. (NASDAQ:HLIT) today announced that its Rhozet(TM) Carbon Coder(TM) universal media transcoding solution has won the Streaming Media 2009 Readers' Choice Award in one of the two Encoding Software categories. Winners were announced November 19 at a reception in San Jose as part of the Streaming Media West conference. This year's selection by Streaming Media readers follows last year's recognition of Carbon Coder as a "Streaming Media Editors' Pick," representing one of the 10 most outstanding products for the streaming media industry.
"The Streaming Media Readers' Choice Awards are the only awards of their kind in the online video industry," said Streaming Media Magazine Editor Eric Schumacher-Rasmussen. "While other awards focus exclusively on content, this is the only awards program that honors the technology that makes it all possible, and it's definitely the only one where the people decide who wins. And this year, more than 5,000 votes were cast for more than 200 nominees. Clearly, people care deeply about the tools they use to get their jobs done." "This vote of confidence from Streaming Media readers confirms that we are successfully tackling the key concerns of how to achieve cost-effective, high-quality transcoding," said David Trescot, Vice President of the Rhozet Business Unit at Harmonic Inc. "The Carbon Coder family of transcoding solutions continues to gain momentum in the marketplace, securing Harmonic's position as a leading provider of scalable, enterprise-level transcoding." Carbon Coder is a universal media transcoding solution used by leading media companies including Ascent Media Group, British Sky Broadcasting (BskyB), Lifetime Networks, MTV, Yahoo! and YouTube to facilitate the creation of multi-format video for Internet, mobile and broadcast applications. Multiple Carbon Coder nodes can be configured as a rendering farm, controlled by one or more Carbon Servers, for distributed enterprise transcoding. Additionally, Carbon QC brings automated compliance and quality testing to the transcoding workflow.
About Harmonic Inc.
Harmonic Inc. is redefining video delivery with the industry's most powerful solutions for delivering live and on-demand video to TVs, PCs and mobile devices. Harmonic's 20 years of technical innovation and market leadership enable the company to offer a unique and comprehensive solution portfolio--including encoding, transcoding, content preparation, stream processing, asset management, edge processing, and delivery. Broadcast, cable, Internet, mobile, satellite and telecom service providers around the world choose Harmonic's IP-based digital video, software, and broadband edge and access solutions. Using these award-winning and industry-leading solutions, operators can reduce costs and differentiate their services by offering consumers a higher quality, personalized multi-screen experience.
Rhozet, a business unit of Harmonic Inc., is dedicated to providing accelerated high-quality media transcoding solutions. The Rhozet solutions are offered in both off-the-shelf and customized software configurations for the production and content delivery markets. For more information about Rhozet technology please visit www.rhozet.com.
Harmonic (NASDAQ: HLIT) is headquartered in Sunnyvale, California with R&D, sales and system integration centers worldwide. The company's customers, including many of the world's largest communications providers, deliver services in virtually every country. Visit www.harmonicinc.com for more information.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: HWAY - Healthways, Inc.)
LATEST NEWS!!
Healthways to Provide SilverSneakers Fitness Program to Physicians Health Choice Members in Four States
NASHVILLE, Tenn., Nov 25, 2009 -- Healthways, Inc. (NASDAQ: HWAY) and Physicians Health Choice today announced an agreement to provide the Healthways SilverSneakers(R) Fitness Program, the nation's leading exercise program for older adults, to eligible Physicians Health Choice plan members in Texas, Florida, New Mexico and Arkansas beginning in January 2010.
SilverSneakers, the award-winning fitness program offering an innovative blend of physical activity, healthy lifestyle direction and social opportunities, helps Medicare-eligible individuals take greater control of their health and maintain an active, independent lifestyle. Studies have found older adults who participate in SilverSneakers are admitted to the hospital less often, have lower overall healthcare costs and a significantly lower risk of depression.
"Today, it is more important than ever for our nation to focus on promoting wellness and prevention at any age," said Ben R. Leedle, Jr., chief executive officer of Healthways. "Our agreement with Physicians Health Choice will expand well-being services and improve the health of thousands of people throughout the South." With the SilverSneakers premier network, Physicians Health Choice members will receive access to a variety of participating fitness and wellness locations. Many sites offer amenities such as fitness equipment, treadmills and free weights, in addition to the signature SilverSneakers Fitness Program classes designed specifically for older adults and taught by certified instructors. Signature classes, such as YogaStretch and SilverSplash(R), may also be available at select locations. A designated staff member will assist members along the way.
"Physicians Health Choice is dedicated to providing benefits, such as SilverSneakers, that help keep our members healthy," said Dr. Robert Grossman, medical director at Physicians Health Choice. "SilverSneakers provides a proven system for helping older adults get fit, have fun and make friends, and we encourage our members to take advantage of this unique benefit." About Physicians Health Choice A physician-owned company, Physicians Health Choice is contracted with the Centers for Medicare & Medicaid Services (CMS) to provide Medicare Advantage health plans to meet the needs of those eligible for Medicare. Headquartered in San Antonio, Texas, Physicians Health Choice began operations in 2005 as a subsidiary of WellMed Medical Management, Inc. - a medical management company based in San Antonio, Texas with more than 18 years of experience providing the highest quality care to over 83,000 older adults in San Antonio and Austin, Texas and along Florida's Treasure Coast.
Today, Physicians Health Choice offers more than 30 Medicare Advantage health plans to more than 19,000 members across the southern US - including Austin, Corpus Christi, El Paso and the Rio Grande Valley in Texas; Las Cruces and Alamogordo, New Mexico; Little Rock, Arkansas and Ft. Lauderdale, Florida.
About Healthways Healthways is the leading provider of specialized, comprehensive solutions to help millions of people maintain or improve their health and well-being and, as a result, reduce overall costs. Healthways' solutions are designed to help healthy individuals stay healthy, mitigate and slow the progression to disease associated with family or lifestyle risk factors and promote the best possible health for those already affected by disease. Our proven, evidence-based programs provide highly specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, internet and face-to-face interactions, both domestically and internationally. Healthways also provides a national, fully accredited complementary and alternative Health Provider Network and a national Fitness Center Network, offering convenient access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system. For more information, please visit www.healthways.com.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ILMN - Illumina, Inc.)
LATEST NEWS!!
Illumina Announces $100 Million Share Repurchase Program
SAN DIEGO, Nov 25, 2009 -- Illumina, Inc. (NASDAQ:ILMN) today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.
"Considering the strength of our balance sheet and our prospects for continued strong cash generation from our operations, this repurchase program is an effective means to return value to our shareholders," said Jay Flatley, Illumina's president and chief executive officer.
Under the program authorized by the company's Board of Directors, shares may be purchased either through open market purchases or under a 10b5-1 trading program. The purchases will be funded from existing cash balances.
A trading program under Rule 10b5-1 allows a company to purchase its shares at times when it otherwise might be prevented from doing so under insider trading laws or self-imposed trading blackout periods. A broker selected by Illumina will have the authority under the terms and limitations specified in the plan to repurchase shares on the company's behalf in accordance with the terms of the plan.
About Illumina Illumina is a leading developer, manufacturer, and marketer of next-generation life science tools and integrated systems for the large scale analysis of genetic variation and biological function. We provide a comprehensive line of proprietary products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, academic institutions, agriculture and livestock companies, pharmaceutical companies, clinical research organizations and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function that will enhance drug discovery and clinical research, allow diseases to be detected earlier and permit better choices of drugs for individual patients.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: INCY - Incyte Corp.)
LATEST NEWS!!
Incyte and Novartis form licensing agreement for two haematology-oncology programmes
Nov 25, 2009 -- Drug discovery and development company Incyte Corp (NASDAQ:INCY) declared on Wednesday that it has signed a collaboration and licence agreement with Novartis for two of its investigational haematology-oncology therapies.
The agreement covers INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterised by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
Under the agreement Incyte will retain exclusive rights for the development and potential commercialisation of INCB18424 in the US, is eligible to receive royalties on future sales of INCB28060 and has retained an option to co-develop and co-promote INCB28060.
Novartis will be responsible for the future development and commercialisation of INCB18424 in all haematology--oncology indications outside of the US and will also be responsible for the future worldwide development of INCB28060. A Novartis will make an upfront payment of USD150m to Incyte plus an immediate USD60m milestone payment for the initiation of the European Phase III trial of INCB18424, COMFORT-II, that started in July.
Incyte may be eligible over time for additional payments of up to approximately USD1.1bn if future contingent development and commercialisation milestones are achieved.
------------------------------------------------------------------------------------------------------------------------------------------------------------
About StockMarketingInc.com
StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back To Contact Center Solutions Homepage's Homepage ]
|
NextiraOne Obtains Cisco's Unified Contact Centre Enterprise ATP Status 
SVP Ireland minimises administration costs and will benefit from returns on investment with integrated system from m-hance
NEW Consolidating Infrastructures: IT's New Call to Business [white paper]
